Source: ICR New class of precision medicine strips cancer of its DNA defenses A new precision medicine targeting cancer's ability to repair its DNA has shown promising results in the first clinical trial of the drug class. The new study, designed to test the drug's safety,
Photo courtesy of: NCI Starve a tumor, feed a cell: How cancers can resist drugs Biologists discover new approach for overcoming drug resistance With drug resistance a major challenge in the fight against cancer, a discovery by University of California, Irvine biologists could offer new approaches to
Photo courtesy of: NCI New front opened in fight against common cancer driver Walter and Eliza Hall Institute researchers have revealed a new vulnerability in lymphomas that are driven by one of the most common cancer-causing changes in cells. The team revealed that the protein MNT is
Photo courtesy of: NCI Cancer-causing culprits will be caught by their DNA fingerprints Causes of cancer are being catalogued by a huge international study revealing the genetic fingerprints of DNA-damaging processes that drive cancer development. Researchers from the Wellcome Sanger Institute, Duke-NUS Medical School Singapore, University of
Photo courtesy of: NCI Visuals Online Mitochondria are the 'canary in the coal mine' for cellular stress How some cancers resist chemotherapy Mitochondria, tiny structures present in most cells, are known for their energy-generating machinery. Now, Salk researchers have discovered a new function of mitochondria: they set
I recently attended the Artificial Intelligence in Oncology conference at Case Comprehensive Cancer Center. Vinay Varadan, Ph.D led a panel discussion on the use of AI in pathology and genomics. Some of the discussions detailed a operating system for precision medicine, Tempus, which can aid oncologists by using
